| Application no. and date | 00968692.4 (espacenet) (Federated) (European Patent Register), 20001005 | | Patent/reg. no. and date | DK/EP 1225870, 20061227 | | Publication date | 20020731 | | Priority no. and date | US 412681, 19991005 | | EP pub. no. and date |
EP 1225870 20020731 | | Effective date | | | Applicant/owner | TVAX BIOMEDICAL I., LLC, 500 West 112th Street
Kansas, MO 64114, US | | Applicant ref. no. | P16582DKEP | | Inventor | Wood, Gary W., 500West 112th Street
Kansas City, MO 64114, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/19 (2006.01) , A61K 39/00 (2006.01) , A61K 45/00 (2006.01) , A61K 9/00 (2006.01) | | Title | Sammensætning og fremgangsmåde til cancerantigenimmunterapi | | Int. application no. | US2000027399 | | Int. publication no. | WO2001024771 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
